|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fonofos | CAS 944-22-9 | ||
| C10H15OPS2 | RTECS TA5950000 | ||
|
Synonyms & Trade Names Dyfonate®, Dyphonate, O-Ethyl-S-phenyl ethylphosphorothioate, Fonophos |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 0.1 mg/m3 [skin] | ||
| OSHA PEL�: none | |||
| IDLH N.D. | Conversion 1 ppm = 10.07 mg/m3 | ||
|
Physical Description Light-yellow liquid with an aromatic odor. [insecticide] |
|||
|
MW: 246.3 |
BP: ? |
FRZ: ? |
Sol: 0.001% |
|
VP(77°F): 0.0002 mmHg |
IP: ? |
|
Sp.Gr: 1.15 |
|
Fl.P: >201°F |
UEL: ? |
LEL: ? |
|
| Class IIIB Combustible Liquid: Fl.P. at or above 200�F. | |||
|
Incompatibilities & Reactivities None reported |
|||
|
Measurement Methods NIOSH 5600; OSHA PV2027 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
| Respirator Recommendations To be added later | |
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Nausea, vomiting, abdominal cramps, diarrhea, salivation; headache, dizziness, lassitude (weakness, exhaustion); rhinorrhea (discharge of thin mucus), chest tightness; blurred vision, miosis; cardiac irregularities; muscle fasciculation; dyspnea (breathing difficulty) | |
|
Target Organs
respiratory system, central nervous system, cardiovascular system, blood cholinesterase |
|
| See also: INTRODUCTION |